|
US4440859A
(en)
|
1977-05-27 |
1984-04-03 |
The Regents Of The University Of California |
Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
|
|
US4704362A
(en)
|
1977-11-08 |
1987-11-03 |
Genentech, Inc. |
Recombinant cloning vehicle microbial polypeptide expression
|
|
IE53176B1
(en)
|
1978-12-22 |
1988-08-17 |
Biogen Nv |
Recombinant dna molecules and their method of production
|
|
US4530901A
(en)
|
1980-01-08 |
1985-07-23 |
Biogen N.V. |
Recombinant DNA molecules and their use in producing human interferon-like polypeptides
|
|
US4342566A
(en)
|
1980-02-22 |
1982-08-03 |
Scripps Clinic & Research Foundation |
Solid phase anti-C3 assay for detection of immune complexes
|
|
US4678751A
(en)
|
1981-09-25 |
1987-07-07 |
Genentech, Inc. |
Hybrid human leukocyte interferons
|
|
US4766075A
(en)
|
1982-07-14 |
1988-08-23 |
Genentech, Inc. |
Human tissue plasminogen activator
|
|
US4582800A
(en)
|
1982-07-12 |
1986-04-15 |
Hoffmann-La Roche Inc. |
Novel vectors and method for controlling interferon expression
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
|
US4677063A
(en)
|
1985-05-02 |
1987-06-30 |
Cetus Corporation |
Human tumor necrosis factor
|
|
US4810648A
(en)
|
1986-01-08 |
1989-03-07 |
Rhone Poulenc Agrochimie |
Haloarylnitrile degrading gene, its use, and cells containing the gene
|
|
US4897445A
(en)
|
1986-06-27 |
1990-01-30 |
The Administrators Of The Tulane Educational Fund |
Method for synthesizing a peptide containing a non-peptide bond
|
|
WO1994029347A1
(en)
|
1993-06-03 |
1994-12-22 |
Therapeutic Antibodies Inc. |
Antibody fragments in therapy
|
|
AUPM322393A0
(en)
|
1993-12-24 |
1994-01-27 |
Austin Research Institute, The |
Mucin carbohydrate compounds and their use in immunotherapy
|
|
WO1997026328A1
(en)
|
1996-01-17 |
1997-07-24 |
Imperial College Innovations Limited |
Immunotherapy using cytotoxic t lymphocytes (ctl)
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
US6406705B1
(en)
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US20020177551A1
(en)
*
|
2000-05-31 |
2002-11-28 |
Terman David S. |
Compositions and methods for treatment of neoplastic disease
|
|
WO2001044279A2
(en)
|
1999-12-17 |
2001-06-21 |
Chiron Corporation |
Mammalian dishevelled-associated proteins
|
|
EP1259601A2
(en)
|
2000-02-22 |
2002-11-27 |
Ahuva Nissim |
Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
|
|
US20040191260A1
(en)
|
2003-03-26 |
2004-09-30 |
Technion Research & Development Foundation Ltd. |
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
|
|
JP2004503213A
(ja)
|
2000-03-27 |
2004-02-05 |
テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド |
１本鎖クラスｉ主要組織適合性複合体、それをコードする構築物およびそれを生成する方法
|
|
AU2001275246B2
(en)
|
2000-06-05 |
2006-06-29 |
Altor Bioscience Corporation |
T cell receptor fusions and conjugates and methods of use thereof
|
|
US20020048550A1
(en)
|
2000-07-20 |
2002-04-25 |
Vallera Daniel A. |
Radiolabeled immunotoxins
|
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
|
US20050053918A1
(en)
|
2001-05-16 |
2005-03-10 |
Technion Research & Development Foundation Ltd. |
Method of identifying peptides capable of binding to MHC molecules, peptides identified thereby and their uses
|
|
US6867283B2
(en)
|
2001-05-16 |
2005-03-15 |
Technion Research & Development Foundation Ltd. |
Peptides capable of binding to MHC molecules, cells presenting such peptides, and pharmaceutical compositions comprising such peptides and/or cells
|
|
US20070134261A1
(en)
*
|
2001-12-03 |
2007-06-14 |
Hancock Robert E |
Effectors of innate immunity
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
AU2003216341A1
(en)
|
2002-02-20 |
2003-09-09 |
Dyax Corporation |
Mhc-peptide complex binding ligands
|
|
US7311914B2
(en)
|
2002-08-13 |
2007-12-25 |
Ludwig Institute For Cancer Research |
MAGE-A4 antigenic peptides and uses thereof
|
|
US20040091503A1
(en)
*
|
2002-08-20 |
2004-05-13 |
Genitrix, Llc |
Lectin compositions and methods for modulating an immune response to an antigen
|
|
JP4406607B2
(ja)
*
|
2002-08-26 |
2010-02-03 |
オンコセラピー・サイエンス株式会社 |
ペプチド及びこれを含む医薬
|
|
NZ539225A
(en)
|
2002-10-09 |
2006-09-29 |
Avidex Ltd |
Single chain recombinant T cell receptors
|
|
NZ539226A
(en)
|
2002-11-09 |
2008-09-26 |
Medigene Ltd |
T cell receptor display
|
|
US20040096982A1
(en)
|
2002-11-19 |
2004-05-20 |
International Business Machines Corporation |
Methods and apparatus for analysis of mass spectra
|
|
DE602004015064D1
(de)
|
2003-01-06 |
2008-08-28 |
Wyeth Corp |
Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
|
|
GB0304068D0
(en)
|
2003-02-22 |
2003-03-26 |
Avidex Ltd |
Substances
|
|
US20090233318A1
(en)
|
2004-12-28 |
2009-09-17 |
Weidanz Jon A |
Methods of assaying vaccine potency
|
|
US20090075304A1
(en)
|
2004-05-27 |
2009-03-19 |
Weidanz Jon A |
Methods of assaying vaccine potency
|
|
US20090304679A1
(en)
*
|
2004-05-27 |
2009-12-10 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
ES2341802T3
(es)
|
2005-09-05 |
2010-06-28 |
Immatics Biotechnologies Gmbh |
Peptidos asociados a tumores unidos promiscuamente a moleculas del antigeno de leucocito humano (hla) de clase ii.
|
|
PL1760089T3
(pl)
|
2005-09-05 |
2010-03-31 |
Immatics Biotechnologies Gmbh |
Peptydy towarzyszące nowotworom, wiążące się z cząsteczkami klasy I i II antygenów ludzkich leukocytów (HLA) i związana z nimi szczepionka przeciwnowotworowa
|
|
CA2660286A1
(en)
|
2006-08-09 |
2008-02-21 |
Homestead Clinical Corporation |
Organ-specific proteins and methods of their use
|
|
US20090117034A1
(en)
|
2007-06-15 |
2009-05-07 |
Nanhai Chen |
Microorganisms for imaging and/or treatment of tumors
|
|
WO2009026547A1
(en)
|
2007-08-22 |
2009-02-26 |
Receptor Logi, Ltd. |
Methods of assaying vaccine potency
|
|
PL2201100T3
(pl)
|
2007-09-14 |
2016-10-31 |
|
Wzmacnianie zdolności ludzkich komórek prezentujących antygen do stymulacji komórek T i ich zastosowanie w szczepieniu
|
|
WO2009108372A2
(en)
|
2008-02-27 |
2009-09-03 |
Receptor Logic, Inc. |
Antibodies as t cell receptor mimics, methods of production and uses thereof
|
|
US20090263574A1
(en)
|
2008-04-21 |
2009-10-22 |
Quinn Daniel E |
Method of restoring an article
|
|
WO2009151487A1
(en)
|
2008-06-13 |
2009-12-17 |
Receptor Logic, Inc. |
Methods of assaying vaccine potency
|
|
DE102008049136B4
(de)
|
2008-09-26 |
2012-10-25 |
Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e.V. |
Neue Regulatoren des angeborenen Immunsystems
|
|
DK2172211T3
(en)
*
|
2008-10-01 |
2015-02-16 |
Immatics Biotechnologies Gmbh |
Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
|
|
WO2010059742A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Collabrx, Inc. |
Individualized cancer treatment
|
|
AU2010319323B2
(en)
|
2009-11-14 |
2015-01-15 |
Cardiovax, Llc |
Immunomodulatory methods and systems for treatment and/or prevention of atherosclerosis
|
|
US8506964B2
(en)
|
2010-02-05 |
2013-08-13 |
Cardiovax, Llc |
Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
CA2816225A1
(en)
|
2010-10-26 |
2012-05-03 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
|
AU2011336997A1
(en)
|
2010-11-12 |
2013-05-30 |
Cedars-Sinai Medical Center |
Immunomodulatory methods and systems for treatment and/or prevention of hypertension
|
|
EP2637685A1
(en)
|
2010-11-12 |
2013-09-18 |
Cedars-Sinai Medical Center |
Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
|
|
US20130302362A1
(en)
*
|
2010-11-12 |
2013-11-14 |
Cedars-Sinai Medical Center |
Immunomodulatory Compositions, Methods and Systems Comprising Immunogenic Fragments of ApoB-100
|
|
CA2836299A1
(en)
*
|
2011-04-15 |
2012-10-18 |
Genelux Corporation |
Clonal strains of attenuated vaccinia viruses and methods of use thereof
|
|
WO2013057586A1
(en)
|
2011-10-19 |
2013-04-25 |
Oslo Universitetssykehus Hf |
Compositions and methods for producing soluble t - cell receptors
|
|
EP2788012A4
(en)
*
|
2011-11-11 |
2015-08-05 |
Cedars Sinai Medical Center |
COMPOSITIONS AND METHODS OF TREATING NURSE DISEASES
|
|
EP3466439A1
(en)
*
|
2011-12-09 |
2019-04-10 |
Stealth Peptides International, Inc. |
Aromatic-cationic peptides and uses of same
|
|
GB201208293D0
(en)
|
2012-05-11 |
2012-06-20 |
Circassia Ltd |
Hydrochlorice salt of peptide
|
|
GB201209862D0
(en)
*
|
2012-06-01 |
2012-07-18 |
Circassia Ltd |
Cladosporium peptides
|
|
US10682399B2
(en)
*
|
2012-09-05 |
2020-06-16 |
The University Of Birmingham |
Target peptides for colorectal cancer therapy and diagnostics
|
|
WO2014071978A1
(en)
|
2012-11-08 |
2014-05-15 |
Roche Diagnostics Gmbh |
Nucleic acids encoding chimeric polypeptides for library screening
|
|
GB201301632D0
(en)
|
2013-01-30 |
2013-03-13 |
Imp Innovations |
Complement System
|
|
US9134326B2
(en)
*
|
2013-03-14 |
2015-09-15 |
Battelle Memorial Institute |
Biomarkers for liver fibrosis
|
|
EP2808392A1
(en)
|
2013-05-28 |
2014-12-03 |
Rheinische Friedrich-Wilhelms-Universität Bonn |
Aptamers and use of the aptamers in the diagnosis and treatment of cancer
|
|
CN103739667B
(zh)
|
2013-09-24 |
2017-08-25 |
上海宇研生物技术有限公司 |
卵巢癌特异的肿瘤抗原肽及其制备方法
|
|
RU2722696C2
(ru)
|
2014-03-14 |
2020-06-03 |
Иммунокор Лимитед |
Библиотеки tcr
|
|
SG10202102698VA
(en)
*
|
2014-12-23 |
2021-04-29 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (hcc) and other cancers
|
|
GB201501017D0
(en)
|
2014-12-23 |
2015-03-04 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides for use in immunotherapy against hepatocellular carcinoma (HCC) and other cancers
|
|
GB201507719D0
(en)
|
2015-05-06 |
2015-06-17 |
Immatics Biotechnologies Gmbh |
Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
US20180179283A1
(en)
|
2015-06-08 |
2018-06-28 |
Adicet Bio Inc. |
T cell receptor like antibodies having fine specificity
|
|
ES2788188T5
(es)
|
2016-04-08 |
2023-10-24 |
Adaptimmune Ltd |
Receptores de linfocitos T
|
|
DK3440102T3
(da)
|
2016-04-08 |
2024-07-22 |
Adaptimmune Ltd |
T-cellereceptorer
|
|
HUE056433T2
(hu)
|
2016-04-08 |
2022-02-28 |
Adaptimmune Ltd |
T-sejt receptorok
|
|
WO2018022573A1
(en)
|
2016-07-27 |
2018-02-01 |
Sharp Laboratories Of America, Inc. |
Wireless telecommuncations methods and apparatus using system information value tag
|
|
JP7303750B2
(ja)
|
2017-01-24 |
2023-07-05 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
癌における非古典的ｈｌａ－ｉおよびネオ抗原を含む複合体を標的とするための方法および組成物
|
|
US20200325244A1
(en)
|
2020-05-18 |
2020-10-15 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|
|
EP3636761B1
(en)
|
2017-06-05 |
2024-07-31 |
Mie University |
Antigen-binding protein recognizing mage-a4-derived peptide
|
|
AU2018298422B2
(en)
|
2017-07-04 |
2023-04-06 |
CureVac SE |
Novel nucleic acid molecules
|
|
JP2021500852A
(ja)
|
2017-08-18 |
2021-01-14 |
グリットストーン オンコロジー インコーポレイテッド |
共有抗原を標的にする抗原結合タンパク質
|
|
US12221465B2
(en)
|
2017-09-06 |
2025-02-11 |
California Institute Of Technology |
Signaling and antigen-presenting bifunctional receptors (SABR)
|
|
CA3086923A1
(en)
|
2017-12-28 |
2019-07-04 |
Gritstone Oncology, Inc. |
Antigen-binding proteins targeting shared antigens
|
|
WO2019204683A1
(en)
|
2018-04-19 |
2019-10-24 |
Board Of Regents, The University Of Texas System |
T cell receptors with mage-b2 specificity and uses thereof
|
|
EP3796927A4
(en)
|
2018-05-23 |
2022-04-20 |
Gritstone bio, Inc. |
Shared antigens
|
|
US20200291128A1
(en)
|
2020-05-18 |
2020-09-17 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|
|
US20200291116A1
(en)
|
2020-05-18 |
2020-09-17 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|
|
US20200291127A1
(en)
|
2020-05-18 |
2020-09-17 |
Abexxa Biologics, Inc. |
Antibodies and methods of use thereof
|